Research reveals a radiomic risk signature predicting survival in glioma patients, indicating the role of biological pathways.
Motivation: The biological mechanisms underlying DSC-PWI-based prognostic radiomic models remain poorly understood. Goal(s): To uncover the biological basis of prognostic radiomic models in glioma patients using paired DSC-PWI and RNA-seq data. Approach: A radiomic risk signature (RRS) for overall survival prediction was developed using preoperative DSC-PWI. Gene Set Enrichment Analysis and Weighted Gene Co-expression Network Analysis were employed to identify biological pathways associated with the RRS and individual prognostic radiomic features, utilizing both DSC-PWI and RNA-seq data. Results: The RRS independently predicted patient survival. The biological basis of prognostic radiomic models involve key pathways related to angiogenesis-hypoxia, immunity and proliferation. Impact: Our work presents an accurate and biologically meaningful tool for survival prediction in gliomas, facilitating personalized clinical decision-making through a non-invasive approach.
No takes yet. Share an insight, caveat, or question.
Yan et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: